BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1794 related articles for article (PubMed ID: 16781921)

  • 1. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
    Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease.
    Grasso S; Leone A; De Michele M; Anaclerio R; Cafarelli A; Ancona G; Stripoli T; Bruno F; Pugliese P; Dambrosio M; Dalfino L; Di Serio F; Fiore T
    Crit Care Med; 2007 Jan; 35(1):96-105. PubMed ID: 17095948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
    Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
    Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
    El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.
    Berdagué P; Caffin PY; Barazer I; Vergnes C; Sedighian S; Letrillard S; Pilossof R; Goutorbe F; Piot C; Reny JL
    Am Heart J; 2006 Mar; 151(3):690-8. PubMed ID: 16504634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.
    Januzzi JL; van Kimmenade R; Lainchbury J; Bayes-Genis A; Ordonez-Llanos J; Santalo-Bel M; Pinto YM; Richards M
    Eur Heart J; 2006 Feb; 27(3):330-7. PubMed ID: 16293638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
    Januzzi JL; Sakhuja R; O'donoghue M; Baggish AL; Anwaruddin S; Chae CU; Cameron R; Krauser DG; Tung R; Camargo CA; Lloyd-Jones DM
    Arch Intern Med; 2006 Feb; 166(3):315-20. PubMed ID: 16476871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
    Januzzi JL; Camargo CA; Anwaruddin S; Baggish AL; Chen AA; Krauser DG; Tung R; Cameron R; Nagurney JT; Chae CU; Lloyd-Jones DM; Brown DF; Foran-Melanson S; Sluss PM; Lee-Lewandrowski E; Lewandrowski KB
    Am J Cardiol; 2005 Apr; 95(8):948-54. PubMed ID: 15820160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
    Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL
    Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score.
    Baggish AL; Siebert U; Lainchbury JG; Cameron R; Anwaruddin S; Chen A; Krauser DG; Tung R; Brown DF; Richards AM; Januzzi JL
    Am Heart J; 2006 Jan; 151(1):48-54. PubMed ID: 16368291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal pro B-type natriuretic peptide testing for short-term prognosis in breathless older adults.
    Chenevier-Gobeaux C; Allo JC; Arthaud M; Achkar R; Claessens YE; Ekindjian OG; Riou B; Ray P
    Am J Emerg Med; 2008 Jun; 26(5):555-60. PubMed ID: 18534284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 90.